Warning! GuruFocus detected
1 Severe warning sign
with NRXP.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
NRX Pharmaceuticals Inc
NAICS : 541714
SIC : 2834
ISIN : US6294441000
Share Class Description:
NRXP: Ordinary SharesDescription
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.22 | |||||
| Equity-to-Asset | -6.36 | |||||
| Debt-to-Equity | -0.28 | |||||
| Debt-to-EBITDA | -0.26 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 51 | |||||
| 3-Year EPS without NRI Growth Rate | 69.7 | |||||
| 3-Year FCF Growth Rate | 50.1 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.11 | |||||
| 9-Day RSI | 29.3 | |||||
| 14-Day RSI | 34.74 | |||||
| 3-1 Month Momentum % | -21.19 | |||||
| 6-1 Month Momentum % | 37.66 | |||||
| 12-1 Month Momentum % | -59.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.15 | |||||
| Quick Ratio | 0.15 | |||||
| Cash Ratio | 0.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -35.4 | |||||
| Shareholder Yield % | -6.02 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -513.19 | |||||
| ROIC % | -171.3 | |||||
| 3-Year ROIIC % | 1307.89 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.41 | |||||
| EV-to-Forward-EBIT | -1.78 | |||||
| EV-to-EBITDA | -1.41 | |||||
| EV-to-Forward-Revenue | 0.48 | |||||
| EV-to-FCF | -3.3 | |||||
| Earnings Yield (Greenblatt) % | -70.92 | |||||
| FCF Yield % | -35.53 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NRXP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NRX Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -9.07 | ||
| Beta | 1.58 | ||
| 3-Year Sharpe Ratio | -0.25 | ||
| 3-Year Sortino Ratio | -0.37 | ||
| Volatility % | 119.75 | ||
| 14-Day RSI | 34.74 | ||
| 14-Day ATR ($) | 0.200515 | ||
| 20-Day SMA ($) | 2.0615 | ||
| 12-1 Month Momentum % | -59.23 | ||
| 52-Week Range ($) | 1.1 - 6.01 | ||
| Shares Outstanding (Mil) | 16.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NRX Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NRX Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
NRX Pharmaceuticals Inc Frequently Asked Questions
What is NRX Pharmaceuticals Inc(NRXP)'s stock price today?
The current price of NRXP is $1.77. The 52 week high of NRXP is $6.01 and 52 week low is $1.10.
When is next earnings date of NRX Pharmaceuticals Inc(NRXP)?
The next earnings date of NRX Pharmaceuticals Inc(NRXP) is 2025-05-14 Est..
Does NRX Pharmaceuticals Inc(NRXP) pay dividends? If so, how much?
NRX Pharmaceuticals Inc(NRXP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers